Global Pharm acquires Qingdao Likang

Global Pharm Holdings Group, Inc. (OTCBB: GPHG) ("Global Pharm" or the "Company"), a China-based, growing vertically integrated pharmaceutical company engaged in pharmaceutical-related products distribution, Traditional Chinese Medicine ("TCM") herbs cultivation and processing business through its subsidiaries in Anhui, Jilin, Guangdong and Shandong provinces, today announced that, on October 31, 2011, it completed the acquisition of the 100% equity interest of Qingdao Likang Pharmaceutical Co., Ltd ("Qingdao Likang"), a city-level pharmaceutical distributor located in Qingdao, Shandong Province. With the completion of this acquisition, Qingdao Likang becomes an indirect wholly owned subsidiary of the Company.

"We are pleased to announce the completion of this acquisition, which brings us to a total of six companies acquired this year. Following the earlier acquisitions of three city-level pharmaceutical distributors in Shandong Province, this addition further extends our distribution coverage into the city of Qingdao and provides us with critical access to Shandong Peninsula, one of the most economically developed regions in China with a relatively higher level of consumption for pharmaceutical products," stated Mr. Yun-lu Yin, Chief Executive Officer of Global Pharm. "For the rest of 2011, we will focus on integrating these newly acquired businesses into our current operations. Through our efforts, we believe that we will be able to broaden our regional market coverage, expand our customer base, diversify our product portfolios and enhance and maintain our position in the Shandong pharmaceutical market."